Kymera Therapeutics KYMR Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Kymera Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kymera Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kymera Therapeutics's operating margin?
- Kymera Therapeutics (KYMR) reported operating margin of -697.7% in Q1 2026.
- How has Kymera Therapeutics's operating margin changed year-over-year?
- Kymera Therapeutics's operating margin decreased by 47.7% year-over-year, from -472.5% to -697.7%.
- What is the long-term trend for Kymera Therapeutics's operating margin?
- Over 5 years (2020 to 2025), Kymera Therapeutics's operating margin has grown at a 45.6% compound annual growth rate (CAGR), from -136.1% to -891.1%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.